Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.609 | Systemic Absorption of Oral Vancomycin Used for the Treatment of Clostridioides Difficile-Associated Diarrhea |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2025.817 | Acute Change in Kidney Function Following Concomitant Initiation of SGLT2 Inhibitors and RAAS Inhibitors: Retrospective Case Control Study |
Prof. Szeto Cheuk Chun 司徒卓俊 |
| 2025.853 | A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL) | Prof. SZETO Cheuk Chun |
| 2024.381 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.402 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.429 | A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) | Prof. SZETO Cheuk Chun |
| 2025.857 | Metabolic-Dysfunction Associated Chronic Kidney Disease: Is it a Real Entity? |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2025.385 | A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2016.721 | Urinary Mitochondrial DNA Level as a Biomarker of Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2017.368 | Urinary Sediment RNA Profile for the Prediction of Therapeutic Response in Lupus Nephritis |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2014.564 | Urinary Podocyte mRNA as a Prognostic Marker of Diabetic Nephropathy | Prof. SZETO Cheuk Chun |
| 2014.352 | Long Non-Coding RNA (IncRNA) in the Urinary Sediment of Patients with Chronic Kidney Disease | Professor SZETO Cheuk Chun |
| 2016.483 | Cost-effectiveness analysis of screening of BK virus-associated nephropathy using urine cytology and serum quantitative polymerase chain reaction |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2017.420 | Urinary miRNA profile as the biomarker of IgA nephropathy |
Prof Szeto Cheuk Chun 司徒卓俊 |
| 2016.480 | Urinary RNA Levels as Prognostic Indicators of Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2015.228 | Relation Between Peritoneal Dialysis Effluent microRNA Level and Longitudinal Change in Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2015.327 | The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients with High Dialysis Effluent Bacterial DNA Fragment Levels |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2014.482 | A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy | Prof. SZETO Cheuk Chun |
| 2015.250 | Genetic Determinants of Peritoneal Transport Characteristics and Cardiovascular Diseases for Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2026.556 | A Phase 3, Single-Arm, Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy | Prof. Szeto Cheuk Chun |
| 2026.193 | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered PYC-003, a Peptide-Phosphorodiamidate Morpholino Oligonucleotide Conjugate, in Healthy Adult Participants and Adult Participants with Confirmed PKD1 Mutation-Associated Autosomal Dominant Polycystic Kidney Disease | Prof. SZETO Cheuk Chun |
| 2026.584 | A Phase IIIb, multi-center, two-arm, randomized, doubleblind, parallel group study to evaluate the efficacy and safety of zigakibart and atrasentan versus zigakibart and placebo in patients with primary IgA nephropathy (LUMINA IgAN) | Prof. Szeto Cheuk Chun |
| 2026.196 | Prevalence and Prognostic Significance of the FIFA (Frailty, Inflammation, Fluid-Overload, and Atherosclerosis) Complex in Incident Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2026.361 | Personalized Peritoneal Dialysis Prescription by Early Assessment of Peritoneal Transport Status Before Home Dialysis Training |
Prof. Szeto Cheuk Chun 司徒卓俊 |
| 2009.479 | Urinary Micro-RNA Profiling as a Prognostic Indicator of Chronic Kidney Diseases | Prof. SZETO Cheuk Chun |
| 2012.048 | Long-Term Outcome of Biopsy-Proven Minimal-Change Nephrotic Syndrome in Children | Prof. SZETO Cheuk Chun |
| 2012.050 | Long-Term Outcome of Biopsy-Proven Minimal-Change Nephrotic Syndrome in Adult | Prof. SZETO Cheuk Chun |
| 2008.257 | Monitoring of Urinary Messenger RNA Expression for the Prediction of Flare in Systemic Lupus Erythematosus | Prof Szeto Cheuk Chun |
| 2012.122 | The role of Extracellular Microvesicle miR-21 as a Mediator Of Progressive Renal Tubulointerstital Fibrosis | Prof. Szeto Cheuk Chun |
| 2012.541 | Circulating Mitochondrial-Derived DNA Fragments: A Possible Factor in the Pathophysiology of Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease? | Prof. SZETO Cheuk Chun |
| 2009.356 | Circulating Bacterial-Derived DNA Fragments and Markers of Iinflammation in Peritoneal Dialysis Patients | Prof. SZETO Cheuk Chun |
| 2009.007 | The Prevalence and Prognostic Implication of Malnutrition in Chinese Peritoneal Dialysis Patients | Prof. Szeto Cheuk Chun |
| 2009.009 | Urinary Micro-RNA Level ini Patients with Lupus Nephritis | Prof. Szeto Cheuk Chun |
| 2008.378 | Acute-on-Chronic Renal Failure: Indenticiation of Urinary Biomarkers for the Prediction of Reversibility | Dr. SZETO Cheuk Chun |
| 2009.359 | Bacteria-Derived DNA Fragment in Peritoneal Dialysis Effluent as a Predictor of Relapsing Peritonitis | Prof. SZETO Cheuk Chun |
| 2012.542 | Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis | Prof. SZETO Cheuk Chun |
| 2010.405 | The effect of using ultrapure water for hemodialysis on the circulating levels of bacterial endotoxin and proinflammatory cytokines | Prof. SZETO Cheuk Chun |
| 2009.188 | The Effect of Neutral Peritoneal Dialysis Solution with Minimal Glucose-Degradation-Product on the Body Composition - A Cross-Sectional Study | Prof. SZETO Cheuk Chun |
| 2009.246 | Outcome of Hemodialysis Patients Who had Failed Peritoneal Dialysis | Prof. SZETO Cheuk Chun |
| 2009.478 | Patients Who Default from Follow-up at General Medical Clinic: Characteristic and Prognostic Implications | Prof. SZETO Cheuk Chun |
| 2010.173 | Relation Between Intra-Renal Cytokine Expression and Histological Class of Lupus Nephritis | Prof. SZETO Cheuk Chun |
| 2011.253 | Relation Between microRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics | Prof. SZETO Cheuk Chun |
| 2010.186 | In-Depth Analysis of Patients Who Missed the Appointment of general Medical Clinic | Prof. SZETO Cheuk Chun |
| 2013.253 | Intra-Renal and Urinary Th9 and Th22 Cytokine Gene Expression in Lupus Nephritis | Prof. Szeto Cheuk Chun |
| 2013.530 | Determining the Role of microRNA in Peritoneal Fibrosis by ex vivo Mesothelial Cell Culture from Peritoneal Dialysis Patients | Professor Szeto Cheuk Chun |
| 2009.152 | Urinary Micro-RNA Profiling for the Disease Monitoring of Systemic Lupus Erythematosus | Prof. SZETO Cheuk Chun |
| 2012.311 | Patients Who Default From Follow-up at Renal Specialist Clinic: Characteristics and Prognostic Implications | Prof. SZETO Cheuk Chun |
| 2010.375 | Circulating Bacterial-Derived DNA Fragments in Peritoneal Dialysis | Prof. SZETO Cheuk Chun |
| 2010.376 | Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis | Prof. SZETO Cheuk Chun |
| 2008.276 | Genetic Determinants of Peritoneal Transport Characteristics, Peritonitis and Cardiovascular Risk for Chronic Peritoneal Dialysis Patients | Prof. SZETO Cheuk Chun |
Page 215 of 289.